Suppr
超能文献

NICE recommends kidney cancer drug it previously rejected on cost grounds.

作者信息

Mayor Susan

出版信息

BMJ. 2009 Feb 9;338:b499. doi: 10.1136/bmj.b499.

DOI:10.1136/bmj.b499

PMID:19204038

Abstract

摘要

相似文献

NICE recommends kidney cancer drug it previously rejected on cost grounds.

BMJ. 2009 Feb 9;338:b499. doi: 10.1136/bmj.b499.

Watchdog set to reject four drugs for kidney cancer on the NHS.

BMJ. 2008 Aug 14;337:a1262. doi: 10.1136/bmj.a1262.

Welcome clinical leadership at NICE.

Lancet. 2008 Aug 23;372(9639):601. doi: 10.1016/S0140-6736(08)61249-0.

Economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinoma.

J Clin Oncol. 2008 Aug 20;26(24):3995-4000. doi: 10.1200/JCO.2007.13.2662.

How do cost-effectiveness analyses inform reimbursement decisions for oncology medicines in Canada? The example of sunitinib for first-line treatment of metastatic renal cell carcinoma.

Value Health. 2010 Sep-Oct;13(6):837-45. doi: 10.1111/j.1524-4733.2010.00738.x. Epub 2010 Jun 7.

Cost effectiveness of sunitinib.

J Clin Oncol. 2008 Dec 10;26(35):5829; author reply 5829-30. doi: 10.1200/JCO.2008.19.8101. Epub 2008 Nov 10.

We have a new treatment, but you can't afford it.

J Natl Compr Canc Netw. 2006 Sep;4(8):720-3. doi: 10.6004/jnccn.2006.0063.

NICE celebrates 10th anniversary amid renal cancer drug controversy.

BJU Int. 2009 Apr;103(8):ii-iii. doi: 10.1111/j.1464-410X.2009.08579.x.

The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?

BJU Int. 2010 Aug;106(4):453-7. doi: 10.1111/j.1464-410X.2010.09466.x. Epub 2010 Jun 22.

Sunitinib, sorafenib, temsirolimus or bevacizumab in the treatment of metastatic renal cell carcinoma: a review of health economic evaluations.

J Chemother. 2010 Apr;22(2):75-82. doi: 10.1179/joc.2010.22.2.75.

引用本文的文献

Economic burden of renal cell carcinoma: Part I--an updated review.

Pharmacoeconomics. 2011 Apr;29(4):315-29. doi: 10.2165/11586100-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

NICE recommends kidney cancer drug it previously rejected on cost grounds.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译